The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy
Bone Marrow Transplant. 2026 May 27. doi: 10.1038/s41409-026-02919-9.…
Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC study
Br J Haematol. 2026 Apr 29. doi: 10.1111/bjh.70505. Online ahead…
An extraction pipeline for analysis of hematopoietic stem cell transplantation data
Bone Marrow Transplant. 2026 Mar 10. doi: 10.1038/s41409-026-02818-z.…
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMT
Blood Adv. 2026 Mar 4:bloodadvances.2025019367. doi: 10.1182/bloodadvances.2025019367.…
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working Party
Hemasphere. 2026 Feb 24;10(2):e70313. doi: 10.1002/hem3.70313.…
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party
J Hematol Oncol. 2026 Feb 21. doi: 10.1186/s13045-026-01783-w.…
A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry
Hemasphere. 2026 Feb 18;10(2):e70301. doi: 10.1002/hem3.70301.…
Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma
Eur J Haematol. 2026 Feb 6. doi: 10.1111/ejh.70126. Online ahead…
Immune biomarkers of increased infection risk in multiple myeloma
Blood. 2026 Jan 29:blood.2025031744. doi: 10.1182/blood.2025031744.…
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study
EClinicalMedicine. 2026 Jan 9;91:103753. doi: 10.1016/j.eclinm.2025.103753.…
It’s time to reimagine reimbursement for CAR T-cell therapy
Am J Manag Care. 2025 Dec;31(Spec. No. 13):SP922-SP929. doi:…
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC Study
Blood Adv. 2026 Jan 13:bloodadvances.2025018152. doi: 10.1182/bloodadvances.2025018152.…
